RTI Surgical, Inc. (NASDAQ:RTIX) Releases FY17 Earnings Guidance
RTI Surgical, Inc. (NASDAQ:RTIX) issued an update on its FY17 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.04-0.08 for the period, compared to the Thomson Reuters consensus estimate of $0.08. The company issued revenue guidance of $274-280 million, compared to the consensus revenue estimate of $281.40 million.
Shares of RTI Surgical, Inc. (RTIX) opened at 5.50 on Tuesday. The firm has a 50-day moving average price of $5.60 and a 200-day moving average price of $4.40. RTI Surgical, Inc. has a 52-week low of $2.50 and a 52-week high of $6.00. The stock’s market capitalization is $319.69 million.
RTIX has been the subject of a number of research reports. BidaskClub lowered shares of RTI Surgical from a strong-buy rating to a buy rating in a research note on Tuesday, July 25th. TheStreet upgraded shares of RTI Surgical from a d+ rating to a c- rating in a research note on Friday, May 5th. Zacks Investment Research lowered RTI Surgical from a hold rating to a sell rating in a research note on Wednesday, May 3rd. Finally, ValuEngine upgraded RTI Surgical from a sell rating to a hold rating in a research note on Friday, June 2nd.
In related news, CEO Camille Farhat acquired 61,693 shares of RTI Surgical stock in a transaction dated Thursday, May 18th. The stock was purchased at an average cost of $4.65 per share, for a total transaction of $286,872.45. The purchase was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 4.90% of the company’s stock.
WARNING: “RTI Surgical, Inc. (NASDAQ:RTIX) Releases FY17 Earnings Guidance” was originally published by American Banking News and is the property of of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.americanbankingnews.com/2017/08/08/rti-surgical-inc-nasdaqrtix-releases-fy17-earnings-guidance.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.